Jane Street’s INmune Bio INMB Stock Holding History

Jane Street’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$219K	Buy	134,232 +83,288	+163%	+$115K	﹤0.01%	9927
2026 Q1	$57.6K	Buy	50,944 +27,987	+122%	+$39.9K	﹤0.01%	10913
2025 Q4	$35.8K	Sell	22,957 -26,617	-54%	-$47.5K	﹤0.01%	10596
2025 Q3	$103K	Buy	+49,574	New	+$113K	﹤0.01%	10121
2025 Q2	–	Sell	-18,159	Closed	-$142K	–	10218
2025 Q1	$142K	Buy	+18,159	New	+$144K	﹤0.01%	8644
2024 Q4	–	Sell	-14,725	Closed	-$79.4K	–	9970
2024 Q3	$79.4K	Buy	+14,725	New	+$105K	﹤0.01%	9069
2024 Q2	–	Sell	-73,970	Closed	-$869K	–	9762
2024 Q1	$869K	Buy	73,970 +30,836	+71%	+$373K	﹤0.01%	5664
2023 Q4	$486K	Buy	+43,134	New	+$362K	﹤0.01%	6808
2022 Q1	–	Sell	-17,098	Closed	-$175K	–	10649
2021 Q4	$175K	Buy	+17,098	New	+$253K	﹤0.01%	8913
2021 Q2	–	Sell	-12,221	Closed	-$145K	–	10074
2021 Q1	$145K	Buy	+12,221	New	+$220K	﹤0.01%	8472

Other funds holding INMB

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Jane Street's INMB Position: Q2 2026 in Review

Jane Street increased its INmune Bio (INMB) stake by 163% in Q2 2026, buying an estimated $115K and bringing the position to 134,232 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #9927.

Jane Street first reported a position in INMB in Q1 2021 and has held it in 10 quarters since. The position peaked at $869K in Q1 2024. 82 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

Jane Street held 134,232 shares of INmune Bio worth $219K as of Q2 2026.
Jane Street bought 83,288 INmune Bio shares in Q2 2026, an estimated $115K.
INmune Bio made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #9927 holding.
Jane Street first reported a position in INmune Bio in Q1 2021 and has held it in 10 quarters since.
Jane Street's INmune Bio position peaked at $869K in Q1 2024.
82 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.